InvestmentPitch Media Video Discusses LOVE Pharma’s Shareholders’ Letter from CEO Zach Stadnyk
Love Pharma (CSE:LUV) (FSE:G1Q0), an international sexual health and wellness company, has provided a shareholders’ update. Zach Stadnyk, CEO, stated: ” We welcome this opportunity to provide our shareholders with a comprehensive picture of Love’s efforts in building upon its existing portfolio and establishing its future strategic imperatives. Building upon LOVE’s existing product portfolio, which is primarily over the counter, the Company’s strategic imperative is aimed at positioning LOVE as…